CMS Bends Knee Injection Code Policy Under Pressure From Genzyme
This article was originally published in The Gray Sheet
Executive Summary
CMS reversed course with a Dec. 14 decision to pay for viscosupplement injections for osteoarthritic knees under four distinct codes in 2007 following persistent pressure from the products' manufacturers